The mission of Grand Rounds in Urology™ (GRU) is to be the largest, most engaged urology professional community in the world, delivering the best practice information to improve physician performance and, ultimately, better patient outcomes. E. David Crawford, MD, Professor of Surgery, Urology, and Radiation Oncology, and Head of the Section of Urologic Oncology at the University of Colorado Denver in Denver, Colorado, serves as Editor in Chief.

GRU accomplishes its mission in the following ways:

Live Meetings: GRU is an organizer and host of international conferences and symposia that bring together the top thought leaders in the treatment of urologic disease. Our meetings focus on current best treatment practices as well as future trends and directions. These educational programs offer highly interactive dialog with state of the art presentations.

Valuable Information and Online Learning Products: Virtual Grand Rounds, Platinum Lecture Series, Ask the Expert, as well as presentations from international meetings provide the resources urologists need to stay informed. Online courses, CME and non-CME, provide urologists with the best practices for treating patients.

Networking: GRU serves to constantly connect professional learners, faculty experts, and industry partners through its’ live and virtual activities. These opportunities facilitate high-level collaborations to evolve best practices in urologic care.

GRU is published by Carden Jennings Publishing Co., Ltd., an internationally recognized medical publisher and award-winning producer of medical education materials for healthcare professionals in a variety of specialties.


Follow us on Twitter!

Content Partners

Rivanna Health Publication’s Prostatepedia features informal conversations with doctors, patients, and activists about prostate cancer about prostate cancer. Each month we tackle a different topic facing prostate cancer patients today—from how imaging has impacted treatment to dealing with erectile dysfunction after radiation or surgery to the evolving field of immunotherapy.

IOS Press is headquartered in Amsterdam, serving the information needs of scientific and medical communities worldwide. IOS Press publishes over 100 international journals and about 75 book titles each year on subjects ranging from medicine and the natural sciences to computer sciences and mathematics. The company’s two journals Bladder Cancer and Kidney Cancer are forums for important scientific advancements and the advocacy communities in these fields. Bladder Cancer and Kidney Cancer facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the bladder and the kidney, respectively. IOS Press partners with Grand Rounds in Urology to provide access to the latest research (abstracts) published in these journals.

In 2008, when physician leaders of member urology practices began to recognize the need for a formal association to help meet the challenges of the future, the Large Urology Group Practice Association (LUGPA) was established with the purpose of enhancing communication among large groups, allowing for benchmarking of operations, promoting quality clinical outcomes, developing new opportunities, and improving advocacy in the legislative and regulatory arenas. LUGPA has modified its bylaws and now welcomes memberships for all physician colleagues regardless of size. All urologists may benefit from the growing LUGPA network.

Prostate Conditions Education Council (PCEC) was founded in 1989, and is a non-profit 501-3c organization.  A national organization committed to men’s health, PCEC is the nation’s leading resource for information on prostate health. The PCEC is dedicated to saving lives through awareness and the education of men, the women in their lives, as well as the medical community about prostate cancer prevalence, the importance of early detection, and available treatment options, as well as other men’s health issues. The Council – comprised of a consortium of leading physicians, health educators, scientists and prostate cancer advocates – aims to conduct nation wide screenings for men and perform research that will aid in the detection and treatment of prostate conditions.